Cargando…
MRI and PET/MRI in hematologic malignancies
The role of MRI differs considerably between the three main groups of hematological malignancies: lymphoma, leukemia, and myeloma. In myeloma, whole‐body MRI (WB‐MRI) is recognized as a highly sensitive test for the assessment of myeloma, and is also endorsed by clinical guidelines, especially for d...
Autores principales: | Mayerhoefer, Marius E., Archibald, Stephen J., Messiou, Christina, Staudenherz, Anton, Berzaczy, Dominik, Schöder, Heiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217155/ https://www.ncbi.nlm.nih.gov/pubmed/31260155 http://dx.doi.org/10.1002/jmri.26848 |
Ejemplares similares
-
Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients
por: Berzaczy, Dominik, et al.
Publicado: (2017) -
Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study
por: Berzaczy, Dominik, et al.
Publicado: (2019) -
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations
por: Mayerhoefer, Marius E., et al.
Publicado: (2019) -
CT, MRI and PET imaging in peritoneal malignancy
por: Patel, Chirag M., et al.
Publicado: (2011) -
Whole body diffusion weighted MRI – a new view of myeloma
por: Messiou, Christina, et al.
Publicado: (2015)